Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Document › Details

CCS Cell Culture Service GmbH. (6/7/10). "Press Release: Transient Bulk Transfection by Flow Electroporation". Hamburg & Princeton, NJ.

Organisations Organisation CCS Cell Culture Service GmbH
  Group Evotec (Group)
  Organisation 2 MaxCyte Inc.
  Group MaxCyte (Group)
Products Product MaxCyte® STX™ Scalable Transfection System
  Product 2 cell line development (research assays)
Index term Index term CCS Cell Culture Service–MaxCyte: cell transfection technology, 201005 supply purchase MaxCyte STX Scalable Transfection System by CCS
Persons Person Wehmeier (formerly Klotzsche), Oliver (Evotec 201403 VP Business Develoment before CCS Cell Culture Service)
  Person 2 Doerfler, Douglas (Doug) (MaxCyte 201006 CEO)
     


CCS Cell Culture Service has established a new technology which is now offered as a custom service to clients within drug discovery industries. By using the MaxCyte® STX™ Scalable Transfection System CCS is able to transfect batches of up to 10 billion cells in less than 30 minutes. Cell lines, primary cells and stem cells are reproducibly and efficiently transfected while maintaining the integrity of the cells for subsequent assays. As a result, bulk quantities of assay-ready frozen instant cells which are transiently expressing targets of interest can now be rapidly prepared.

“We are very excited about this technology. Difficult targets or target complexes can now be easily addressed in a high-throughput screening scale by using large quantities of validated transiently transfected cells, even in more in vivo-like cellular backgrounds.” comments Dr. Oliver Klotzsche, Managing Director of CCS.

“We are very pleased that CCS has decided to acquire the MaxCyte STX. By providing transient bulk transfection as a custom service, CCS enables everybody to benefit from our technology and helps to get it established as an important tool for drug discovery.” states Douglas Doerfler, President and CEO at MaxCyte.


About CCS Cell Culture Service

CCS is dedicated to improving the output of drug discovery research by providing custom made cell based reagents. For more than ten years, CCS has been supporting the research departments of pharmaceutical and biotechnology companies in their efforts to discover new drug entities. Originally established as a general provider of research services, CCS has advanced to become a custom supplier of recombinant cell lines, assay-ready frozen cells, qualified membranes and proteins for high-throughput-screening. Major pharmaceutical companies all over Europe and the USA now rely on the custom products and services of CCS. (http://www.cellcultureservice.com)

About MaxCyte

MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of innovative therapeutic products. Drawing on its cell therapy expertise, MaxCyte designed the MaxCyte® STX™ Scalable Transfection System for the rapid development and consistent production of (co)transfected primary cells, stem cells, and cell lines for cell-based screening assays for ion channels, GPCRs, and other targets, with comparable results and Seamless Scalability™ from the bench to HTS scale. (http://www.maxcyte.com/cell-based-screening.shtml)

Contact:

CCS Cell Culture Service – USA & Canada
Richard Field
COO, North America
Phone: (732) 329 2355
Email: Field@CellCultureService.com

CCS Cell Culture Service – Europe
Susan Friedemann
Sales & Communication
Phone: +49 (40) 471 965 75
Email: Friedemann@CellCultureService.com

MaxCyte
Karen A. Donato, Ph.D.
Executive Vice President Sales and Marketing
Phone: (301) 944-1700
Email: kdonato@maxcyte.com

   
Record changed: 2017-04-02

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px

More documents for Evotec (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top